Mouse anti Human CD26 | Bio-Rad MCA1317GA product information

product summary

company name :

Bio-Rad

other brands :

Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology

product type :

antibody

product name :

Mouse anti Human CD26

catalog :

MCA1317GA

quantity :

0.1 mg

price :

249 USD

clonality :

monoclonal

host :

mouse

conjugate :

nonconjugated

clone name :

M-A261

reactivity :

human

application :

immunocytochemistry, immunoprecipitation, flow cytometry

more info or order :

Bio-Rad product webpage

citations: 1

Published Application/Species/Sample/Dilution	Reference
immunocytochemistry; human; loading ...; fig 2	Belouzard S, Danneels A, Fénéant L, Séron K, Rouille Y, Dubuisson J. Entry and Release of Hepatitis C Virus in Polarized Human Hepatocytes. J Virol. 2017;91: pubmed publisher

image

image 1 :

Figure A. RPE conjugated mouse anti human CD19 ( MCA1940PE ) and FITC conjugated mouse IgG1 isotype control ( MCA928F ). Figure B. RPE conjugated mouse anti human CD19 ( MCA1940PE ) and FITC conjugated mouse anti human CD26 ( MCA1317F ). All experiments performed on red cell lysed human blood gated on lymphocytes in the presence of 10% human serum. Data acquired on the ZE5 Cell Analyzer.

product information

Entity Type :

Monoclonal Antibody

Entity Category :

Antibodies

ProductCode :

MCA1317GA

Description :

Mouse anti Human CD26

Specificity :

CD26

TargetSpecies :

Human

Host :

Mouse

Format :

Purified

Isotypes :

IgG1

Applications :

P,IP,F,C

ApplicationTypes :

Immunohistology - Paraffin,Immunoprecipitation,Flow Cytometry,Immunohistology - Frozen

Clone :

M-A261

Quantity :

0.1 mg

Quantity Value :

0.1

Quantity Type :

GO Accessions :

GO:0001666,GO:0002020,GO:0004252,GO:0004177,GO:0008239,GO:0005102,GO:0007155,GO:0016021,GO:0005576,GO:0004872,GO:0030139,GO:0006508,GO:0008284,GO:0009986,GO:0010716,GO:0016324,GO:0031258,GO:0031295,GO:0033632,GO:0042110,GO:0042803,GO:0043542,GO:0045121,GO:0071438

GOTerms :

response to hypoxia,protease binding,serine-type endopeptidase activity,aminopeptidase activity,dipeptidyl-peptidase activity,receptor binding,cell adhesion,integral to membrane,extracellular region,receptor activity,endocytic vesicle,proteolysis,positive regulation of cell proliferation,cell surface,negative regulation of extracellular matrix disassembly,apical plasma membrane,lamellipodium membrane,T cell costimulation,regulation of cell-cell adhesion mediated by integrin,T cell activation,protein homodimerization activity,endothelial cell migration,membrane raft,invadopodium membrane

Uniprot Accessions :

P27487

Gene :

DPP4

GeneID URL :

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=1803

Published Synonyms :

DPP4

Entity Formats :

Purified

UNSPSC :

41116161

Concentration :

IgG concentration 1 mg/ml

Product Form :

Purified IgG - liquid

PriceGBP :

178

PriceEUR :

249

PriceUSD :

249 USD

PriceCHF :

271

PriceSEK :

2714

PriceNOK :

2728

PriceDKK :

1856

more info or order :

Bio-Rad product webpage

company information

Bio-Rad

Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE

antibody_sales_uk@bio-rad.com

https://www.bio-rad-antibodies.com

1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)

headquarters: UK

Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.